Bruno Sangro

39PUBLICATIONS

179CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTransplantation immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jun 10, 2026

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

|Mar 19, 2026

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Belén Aparicio, Leyre Silva, Marta Ruiz

|Mar 09, 2026

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Changhoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin

|Dec 16, 2025

Response evaluation to systemic therapy in HCC: Current challenges and future perspectives.

Mario Matute-González, Maxime Ronot, Victoria Chernyak

|Oct 21, 2025

Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.

Shay Behrens, Whitney Leet Do, Limin Wang

|Sep 13, 2025

Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?

Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena

Pageof 7

Frequent Collaborators

Josepmaria Argemí

José Ignacio Bilbao

Jorge Aramburu

Juan Pablo Unfried

Matías A Ávila

Macarena Rodríguez-Fraile

4 joint publications

Raul Antón

4 joint publications

Puri Fortes

4 joint publications

Manuel De la Torre-Aláez

3 joint publications

Juan Carlos Ramos

Frequent Collaborators

Josepmaria Argemí

José Ignacio Bilbao

Jorge Aramburu

Juan Pablo Unfried